Amyloid β causes excitation/inhibition imbalance through dopamine receptor 1-dependent disruption of fast-spiking GABAergic input in anterior cingulate cortex

Alzheimer’s disease (AD) is the most common cause of dementia in the elderly. At the early stages of AD development, the soluble β-amyloid (Aβ) induces synaptic dysfunction, perturbs the excitation/inhibition balance of neural circuitries, and in turn alters the normal neural network activity leading to cognitive decline, but the underlying mechanisms are not well established. Here by using whole-cell recordings in acute mouse brain slices, we found that 50 nM Aβ induces hyperexcitability of excitatory pyramidal cells in the cingulate cortex, one of the most vulnerable areas in AD, via depressing inhibitory synaptic transmission. Furthermore, by simultaneously recording multiple cells, we discovered that the inhibitory innervation of pyramidal cells from fast-spiking (FS) interneurons instead of non-FS interneurons is dramatically disrupted by Aβ, and perturbation of the presynaptic inhibitory neurotransmitter gamma-aminobutyric acid (GABA) release underlies this inhibitory input disruption. Finally, we identified the increased dopamine action on dopamine D1 receptor of FS interneurons as a key pathological factor that contributes to GABAergic input perturbation and excitation/inhibition imbalance caused by Aβ. Thus, we conclude that the dopamine receptor 1-dependent disruption of FS GABAergic inhibitory input plays a critical role in Aβ-induced excitation/inhibition imbalance in anterior cingulate cortex.

[1]  M. Botvinick,et al.  The Contribution of the Anterior Cingulate Cortex to Executive Processes in Cognition , 1999, Reviews in the neurosciences.

[2]  Dominic M. Walsh,et al.  Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.

[3]  Arthur Konnerth,et al.  Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.

[4]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[5]  Keith A. Johnson,et al.  Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.

[6]  Cheng Luo,et al.  Resting-state functional connectivity in anterior cingulate cortex in normal aging , 2014, Front. Aging Neurosci..

[7]  W. Lu,et al.  PKCλ is critical in AMPA receptor phosphorylation and synaptic incorporation during LTP , 2013, The EMBO journal.

[8]  Giada Cellot,et al.  GABAergic Signaling as Therapeutic Target for Autism Spectrum Disorders , 2014, Front. Pediatr..

[9]  Sylvain Rheims,et al.  Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy , 2009, The Journal of Neuroscience.

[10]  Arthur Konnerth,et al.  Impairments of neural circuit function in Alzheimer's disease , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[11]  D. Holtzman,et al.  Amyloid beta and Alzheimer disease therapeutics: the devil may be in the details. , 2003, The Journal of clinical investigation.

[12]  B. Shyu,et al.  Anterior Cingulate epilepsy: mechanisms and modulation , 2014, Front. Integr. Neurosci..

[13]  A. Arnsten,et al.  Dopamine’s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders , 2015, Pharmacological Reviews.

[14]  L. Mucke,et al.  Network abnormalities and interneuron dysfunction in Alzheimer disease , 2016, Nature Reviews Neuroscience.

[15]  E. Leznik,et al.  Microglial Receptor for Advanced Glycation End Product-Dependent Signal Pathway Drives β-Amyloid-Induced Synaptic Depression and Long-Term Depression Impairment in Entorhinal Cortex , 2010, The Journal of Neuroscience.

[16]  B. Rudy,et al.  Perisomatic GABA Release and Thalamocortical Integration onto Neocortical Excitatory Cells Are Regulated by Neuromodulators , 2008, Neuron.

[17]  D. Holtzman,et al.  Amyloid β and Alzheimer disease therapeutics: the devil may be in the details , 2003 .

[18]  P. Goldman-Rakic,et al.  Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Marty,et al.  Presynaptic calcium stores underlie large-amplitude miniature IPSCs and spontaneous calcium transients , 2000, Nature Neuroscience.

[20]  G. Koch,et al.  “Is dopamine involved in Alzheimer's disease?” , 2014, Front. Aging Neurosci..

[21]  K. Finch,et al.  Linking Aβ42-Induced Hyperexcitability to Neurodegeneration, Learning and Motor Deficits, and a Shorter Lifespan in an Alzheimer’s Model , 2015, PLoS genetics.

[22]  H. Markram,et al.  Interneurons of the neocortical inhibitory system , 2004, Nature Reviews Neuroscience.

[23]  Yaakov Stern,et al.  Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.

[24]  H. A. Born,et al.  Seizures in Alzheimer’s disease , 2015, Neuroscience.

[25]  Martin K. Schwarz,et al.  Dysfunction of Somatostatin-Positive Interneurons Associated with Memory Deficits in an Alzheimer’s Disease Model , 2016, Neuron.

[26]  M. Posner,et al.  Cognitive and emotional influences in anterior cingulate cortex , 2000, Trends in Cognitive Sciences.

[27]  G. Blatt,et al.  Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism , 2009, Autism research : official journal of the International Society for Autism Research.

[28]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[29]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[30]  P. Jonas,et al.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks , 2007, Nature Reviews Neuroscience.

[31]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[32]  R. Lukas,et al.  A Novel Nicotinic Mechanism Underlies β-Amyloid-Induced Neuronal Hyperexcitation , 2013, The Journal of Neuroscience.

[33]  Y. Kubota,et al.  GABAergic cell subtypes and their synaptic connections in rat frontal cortex. , 1997, Cerebral cortex.

[34]  D. Ulrich Amyloid-β Impairs Synaptic Inhibition via GABAA Receptor Endocytosis , 2015, The Journal of Neuroscience.

[35]  Dang Sun,et al.  Aβ induces acute depression of excitatory glutamatergic synaptic transmission through distinct phosphatase-dependent mechanisms in rat CA1 pyramidal neurons , 2013, Brain Research.

[36]  M. Seeck,et al.  From here to epilepsy: the risk of seizure in patients with Alzheimer's disease. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[37]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[38]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[39]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[40]  R. Nichols,et al.  Dopamine release in prefrontal cortex in response to β-amyloid activation of α7∗ nicotinic receptors , 2007, Brain Research.

[41]  A. Weible,et al.  Remembering to attend: The anterior cingulate cortex and remote memory , 2013, Behavioural Brain Research.

[42]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[43]  Bert Sakmann,et al.  Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease , 2012, Proceedings of the National Academy of Sciences.

[44]  T. Freund,et al.  Perisomatic Inhibition , 2007, Neuron.

[45]  Michael Falkenstein,et al.  Physical activity and neurocognitive functioning in aging - a condensed updated review , 2016, European Review of Aging and Physical Activity.

[46]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[47]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[48]  K. Nakazawa,et al.  GABAergic interneuron origin of schizophrenia pathophysiology , 2012, Neuropharmacology.

[49]  J. J. Dougherty,et al.  β-Amyloid Regulation of Presynaptic Nicotinic Receptors in Rat Hippocampus and Neocortex , 2003, The Journal of Neuroscience.

[50]  P. Calabresi,et al.  Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? , 2016, Neurobiology of Aging.

[51]  Robert A Nichols,et al.  Dopamine release in prefrontal cortex in response to beta-amyloid activation of alpha7 * nicotinic receptors. , 2007, Brain research.

[52]  P. Goldman-Rakic,et al.  Dopamine Modulation of Perisomatic and Peridendritic Inhibition in Prefrontal Cortex , 2003, The Journal of Neuroscience.

[53]  L. Mucke,et al.  Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.

[54]  John V. Carlis,et al.  Where the brain grows old: Decline in anterior cingulate and medial prefrontal function with normal aging , 2007, NeuroImage.

[55]  G. Fishell,et al.  Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons , 2011, Developmental neurobiology.